Scientists have achieved a major breakthrough in combating ageing and age-related diseases. The study by the researchers from Harvard Medical School and Massachusetts Institute of Technology was published in the journal Aging-US.
Humanity’s attempt to prevent ageing: What is the breakthrough?
The researchers have introduced a chemical method through a ‘single pill’ to reprogram body cells, following which the cells effectively return to a younger state.
The researchers reportedly built upon the Nobel Prize-winning discovery in 2012 that certain genes, known as Yamanaka factors, could transform adult cells into pluripotent stem cells which have unlimited capacity to divide, self-renew and differentiate into cells of early primary germ cell layers, namely mesoderm, endoderm, and ectoderm.
Challenges faced by researchers
The key challenge was to reverse cellular ageing without triggering cancerous growth.
Lead scientist David A. Sinclair, a Professor in the Department of Genetics at Harvard, expressed the significance of this achievement, stating that while aging could previously only be slowed down, it can now potentially be reversed.
Also watch | Gravitas: A step closer to anti-ageing drugs
“This new discovery offers the potential to reverse ageing with a single pill, with applications ranging from improving eyesight to effectively treating numerous age-related diseases,” Sinclair said.
The implications of this discovery are extensive, offering new possibilities for regenerative medicine and the potential for whole-body rejuvenation.
What does it mean for humanity?
By developing a chemical alternative to gene therapy for age reversal, this research has the potential to revolutionise the treatment of ageing, injuries, and age-related diseases, leading to reduced costs and shorter development timelines.
The Harvard team envisions a future where age-related diseases can be effectively treated, injuries can be efficiently repaired, and the dream of whole-body rejuvenation becomes a reality.
